Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2008, p. 1182-1183, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01332-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
Received 16 October 2007/ Returned for modification 15 November 2007/ Accepted 21 December 2007
We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci.
Published ahead of print on 7 January 2008.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»